Home   HELP  /   AYUDA  /   求助 : help-desk@bctrials.org  /   (415) 476-5777 Click to print page  Print
Other options

view Contact Information

Contact Information for Olaparib & Sapacitabine in Patients with Advanced Breast Cancer & Inherited BRCA Mutation

The sites for this trial are listed below.
If you speak with a site, please mention that you were referred by BreastCancerTrials.org

Dana Farber Cancer Institute, Boston, MA,  02215

Contact person: Sara M. Tolaney, MD MPH
Email: Sara_Tolaney@dfci.harvard.edu